Fig. 12From: Adjunctive treatment of chronic migraine using an oral dental device: overview and results of a randomized placebo-controlled crossover studyPercent reduction of migraine events for individual NTI users (Elkhart site) during second month of use in the initial FDA trial studyBack to article page